Cell Therapy Industry
264 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Lee Buckler from Cell Therapy & Regenerative Medicine
Scoop.it!

Gamida Cell shifts focus to NiCord stem cell product

Gamida Cell shifts focus to NiCord stem cell product | Cell Therapy Industry | Scoop.it
Jerusalem-based Gamida Cell is positioned to become a world leader in blood-derived cell therapy. It has developed several platform technologies to expand functional cell populations and a pipeline of cell therapeutics in ...

Via Ella Buzhor
more...
Ella Buzhor's curator insight, March 5, 2014 4:37 AM

NiCord® composed of expanded umbilical cord blood-derived stem cells and transplanted in combination with non-expanded cells. The portion of umbilical stem cells is expanded using Gamida Cell’s proprietary nicotinamide (NAM) technology, which leads to specific ex vivo expansion of functional CD34+ cells. In addition to hematological malignancies, NiCord is in development to treat sickle cell disease, thalassemia, and aplastic anemia.

http://discovery.lifemapsc.com/regenerative-medicine/cell-therapy-applications/blood-nicord-umbilical-cord-blood-derived-stem-progenitor-cells-for-hemotological-diseases

Rescooped by Lee Buckler from Cell Therapy & Regenerative Medicine
Scoop.it!

AC607 (MSCs) for the Treatment of Acute Kidney Injury

AC607 (MSCs) for the Treatment of Acute Kidney Injury | Cell Therapy Industry | Scoop.it
New-York Presbyterian/Columbia University is participating in a trial that is evaluating the use of human bone-marrow (Mesenchymal) derived stem cells (AC607), ...

Via Ella Buzhor
more...
Ella Buzhor's curator insight, July 18, 2013 2:53 AM

Expanded allogeneic bone marrow-derived mesenchymal stem cells (MSCs) for treatment of AKI in cardiac surgery patients. MSCs mediate their therapoetic effect throught paracrine mechanism of action, by secrition of  anti-apoptotic, mitogenic ,anti-inflammatory and angiogenic factors.

Rescooped by Lee Buckler from Stem-Cells
Scoop.it!

Calimmune Initiates HIV Stem Cell Study at Two California Research Sites - Fort Mills Times

Calimmune Initiates HIV Stem Cell Study at Two California Research Sites Fort Mills Times In the study, 12 HIV-positive participants will be infused with their own T cells and stem cells (hematopoietic stem cells, HSC), which have been modified to...

Via Joe Riggs
Lee Buckler's insight:

Calimmune initiates a gene-modified t-cell and stem cell trial for HIV

more...
Pete Shuster's curator insight, July 11, 2013 11:43 AM

Important insight from stem cell expert Lee Buckler

Rescooped by Lee Buckler from Cell Therapy & Regenerative Medicine
Scoop.it!

Cha Bio&Diostech Licenses Pluristem Cell Therapy for PAD in ...

Cha Bio&Diostech Licenses Pluristem Cell Therapy for PAD in ... | Cell Therapy Industry | Scoop.it
Under the terms of the deal Cha will fund and carry out multiple clinical trials in South Korea to evaluate PLX-PAD for treating CLI and IC, under the supervision of the Korea Food & Drug Administration (KFDA).

Via Ella Buzhor
more...
Rescooped by Lee Buckler from Cell Therapy & Regenerative Medicine
Scoop.it!

Stem cell trial produces positive results for ALS patients

Stem cell trial produces positive results for ALS patients | Cell Therapy Industry | Scoop.it

The results suggest that intraspinal stem cell transplantation of ALS subjects with no bulbar symptoms early in the course of their disease could slow disease progression. 

During the first phase of the trial, surgeons injected up to 1.5 million stem cells into either the lumbar, cervical or both parts of the spinal column, first in patients who could not walk and then in those able to walk. The doctors are injecting fetal stem cells provided by Neuralstem Inc., a Maryland company.

Phase II will involve more injections and millions more stem cells and will focus on the upper portion of the spinal column, where nerve cells supply the diaphragm. When those cells are damaged, patients have difficulty breathing, which is a common problem in ALS patients.





Via Ella Buzhor
more...
Ella Buzhor's curator insight, July 8, 2013 4:55 AM

More info regarding the Neural Stem cell therapy [NSI-566 human spinal cord stem cells (HSSCs)] for ALS:

http://www.neuralstem.com/cell-therapy-for-als

Scooped by Lee Buckler
Scoop.it!

Celgene, others regenerate biotech Tengion's finances with $33.6M

Celgene, others regenerate biotech Tengion's finances with $33.6M | Cell Therapy Industry | Scoop.it
Celgene has invested further in the cash-hungry regenerative medicine specialist Tengion, which tapped the biopharma powerhouse and other backers for a total of $33.6 million to support its two lead programs in early clinical development.
more...
No comment yet.
Rescooped by Lee Buckler from Stem-Cells
Scoop.it!

Stem Cell Basics: Educational cartoon for young learners

Take a peek into our microscope for a lesson in stem cell basics! This video is a component of the Pittsburgh Tissue Engineering Iniative-Carnegie Science Ce...

Via Bonnie Bracey Sutton, Joe Riggs
more...
Bonnie Bracey Sutton's curator insight, June 15, 2013 5:37 PM

Engaging lesson on STEM cell basics....share.

Rescooped by Lee Buckler from Dental Implant and Bone Regeneration
Scoop.it!

curasan AG: Dental Business Unit acquired as of June 1

curasan AG: Dental Business Unit acquired as of June 1 | Cell Therapy Industry | Scoop.it

curasan AG, Germany, has acquired a large part of the “Oral Regenerative Medicine” division of Riemser Pharma GmbH, Germany, effective June 1, 2013.


Via Alessandro Dentoni
more...
Scooped by Lee Buckler
Scoop.it!

Stem Cell Reports: Homepage with article | A new open access journal from the ISSCR and Cell Press.

Stem Cell Reports: Homepage with article | A new open access journal from the ISSCR and Cell Press. | Cell Therapy Industry | Scoop.it
A new open-access journal from Cell Press in association with the ISSCR (RT @CellStemCell: It's here!
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Madison stem cell company Cellular Dynamics International files for IPO - 77Square.com

Madison stem cell company Cellular Dynamics International files for IPO - 77Square.com | Cell Therapy Industry | Scoop.it
Madison stem cell company Cellular Dynamics International files for IPO
77Square.com
CDI's customers use the cells for drug discovery, testing products for toxicity and chemical safety, therapeutic research, and stem cell banks.
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Pluristem slumps as FDA suspends stem cell study

Pluristem slumps as FDA suspends stem cell study | Cell Therapy Industry | Scoop.it
NEW YORK-- Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower.
more...
No comment yet.
Rescooped by Lee Buckler from Stem Cells & Tissue Engineering
Scoop.it!

Social media and stem cells: Time to start tweeting - Signals Blog

Social media and stem cells: Time to start tweeting - Signals Blog | Cell Therapy Industry | Scoop.it
'Social media and stem cells: Time to start tweeting' authored by Ben Paylor - interesting for social media users http://t.co/uJzHq9QxGc

Via Jacob Blumenthal
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Brooks Automation and BioCision Announce Equity Investment and Strategic Collaboration

more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Coming of Age: Experts Reflect on the Extraordinary Promise of the Cell Therapy Sector

Coming of Age: Experts Reflect on the Extraordinary Promise of the Cell Therapy Sector | Cell Therapy Industry | Scoop.it
Without innovation and risk-taking, modern medicine would be missing staples of the physician's armamentarium: antibiotics, radiation therapies, vaccines.
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

VC-01 Diabetes Therapy 'Cells' Investors on Viacyte - BioWorld Online

VC-01 Diabetes Therapy 'Cells' Investors on Viacyte - BioWorld Online | Cell Therapy Industry | Scoop.it
IVCPOST
VC-01 Diabetes Therapy 'Cells' Investors on Viacyte
BioWorld Online
Tiny Viacyte Inc. is going after a whopper of an indication with a stem cell-derived cell therapy to treat Type I and insulin-dependent Type II diabetes.
more...
No comment yet.
Rescooped by Lee Buckler from Cell Therapy & Regenerative Medicine
Scoop.it!

Marching Towards Regenerative Cardiac Therapy with Human Pluripotent Stem Cells

Marching Towards Regenerative Cardiac Therapy with Human Pluripotent Stem Cells | Cell Therapy Industry | Scoop.it
Figure 1. Timeline for the development of regenerative cardiac therapy with human pluripotent stem cells. Relevant significant events in regenerative medicine are noted. Studies on hPSCs have been defined and extended by ...

Via Ella Buzhor
more...
No comment yet.
Rescooped by Lee Buckler from Cell Therapy & Regenerative Medicine
Scoop.it!

Cell Stem Cell - Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment

During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.


Via Ella Buzhor
more...
Ella Buzhor's curator insight, July 6, 2013 10:08 AM

Very useful info regarding the cell therapy industry progress.

Scooped by Lee Buckler
Scoop.it!

Paper Raises Hundreds Of Questions About The Integrity Of Stem Cell Research Group

Paper Raises Hundreds Of Questions About The Integrity Of Stem Cell Research Group | Cell Therapy Industry | Scoop.it
Serious questions have been raised about the integrity and validity of research performed by a well-established German stem cell research group. A paper published in the International Journal of Cardiology exhaustively details a multitude of...
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Download: Article by Genzyme on Rapid Microbiological Methods in cell therapy

Download: Article by Genzyme on Rapid Microbiological Methods in cell therapy | Cell Therapy Industry | Scoop.it
John Duguid, Principal Process/Analytical Scientist, Manufacturing Technical Services, at Genzyme Corporation kindly provided this article entitled, ‘Rapid (RT @StemCellsUSA: Interesting article on Rapid Microbiological Methods by John Duguid et al...
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Strategic Acquisition Advances Regenerative Medicine - ThomasNet Industrial News Room (press release)

Strategic Acquisition Advances Regenerative Medicine ThomasNet Industrial News Room (press release) Not only is Instron gaining the knowledge and experience of TGT, but we're now able to provide a full range of solutions for the tissue engineering...
Lee Buckler's insight:

Tissue Regeneration Technologies (TRT) is bought by Instron.

more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Bioengineered blood vessels from Humacyte start clinical trials at Duke :: Editor's Blog at WRAL Tech Wire

Bioengineered blood vessels from Humacyte start clinical trials at Duke :: Editor's Blog at WRAL Tech Wire | Cell Therapy Industry | Scoop.it
A blood vessel grown in a lab was implanted in the first U.S. patient this week. Read more about Humacyte, the RTP firm that developed this regenerative medicine technology.
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

Webinar: Reimbursement Strategies for Stem Cell and Regenerative Medicine Therapies | California's Stem Cell Agency

Webinar: Reimbursement Strategies for Stem Cell and Regenerative Medicine Therapies | California's Stem Cell Agency | Cell Therapy Industry | Scoop.it
Webinar 6/20: Reimbursement Strategies Planning Your Payment Strategy in Early Product Development http://t.co/GD8522JOWr #stemcells
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

PCT inks manufacturing agreement with IMUC for dendritic cell vaccines ... - pharmabiz.com

PCT inks manufacturing agreement with IMUC for dendritic cell vaccines ...
pharmabiz.com
Progenitor Cell Therapy LLC (PCT), a subsidiary of NeoStem, Inc., and ImmunoCellular Therapeutics, Ltd.
more...
No comment yet.
Scooped by Lee Buckler
Scoop.it!

StemCells, Inc. - Investor Relations - RSS Content

StemCells, Inc. - Investor Relations - RSS Content | Cell Therapy Industry | Scoop.it
NASDAQ: STEM. Committed to balancing standards of scientific rigor and clinical integrity with corporate imperatives of value creation and long-term business sustainability.
Lee Buckler's insight:

Seems like Canada may be distinguishing itself as a middle-ground regulatory jurisdiction not unlike Switzerland, Australia, Japan, Singapore, South Korea, etc.  

more...
No comment yet.